Drugs / GSKI181771X
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00600743 Comparator | Jan 2008 → Feb 2009 | bulimia nervosa | St. Luke's-Roosevelt Hospital Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSKI181771X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00600743 ↗ |
| Action | Activate | “oral cholecystokinin (CCK) agonist GSKI181771X” NCT00600743 ↗ |
| Route | Oral | “oral cholecystokinin (CCK) agonist GSKI181771X” NCT00600743 ↗ |